These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11238438)

  • 1. Cost and cost-effectiveness guidelines: which ones to use?
    Walker D
    Health Policy Plan; 2001 Mar; 16(1):113-21. PubMed ID: 11238438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.
    Carias C; Chesson HW; Grosse SD; Li R; Meltzer MI; Miller GF; Murphy LB; Nurmagambetov TA; Pike JJ; Whitham HK
    Am J Prev Med; 2018 Apr; 54(4):600-602. PubMed ID: 29338958
    [No Abstract]   [Full Text] [Related]  

  • 4. Value for money in the health sector: the contribution of primary health care.
    Mills A; Drummond M
    Health Policy Plan; 1987 Jun; 2(2):107-28. PubMed ID: 10312103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation in health care: is there a role for cost-benefit analysis?
    Johannesson M; Jönsson B
    Health Policy; 1991 Feb; 17(1):1-23. PubMed ID: 10113574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of alcoholism treatment.
    Bray JW; Zarkin GA
    Alcohol Res Health; 2006; 29(1):27-33. PubMed ID: 16767850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries.
    Vassall A; Mangham-Jefferies L; Gomez GB; Pitt C; Foster N
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):95-115. PubMed ID: 26786617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis: can we reduce variability in costing methods?
    Adam T; Koopmanschap MA; Evans DB
    Int J Technol Assess Health Care; 2003; 19(2):407-20. PubMed ID: 12862197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting.
    Pitt C; Vassall A; Teerawattananon Y; Griffiths UK; Guinness L; Walker D; Foster N; Hanson K
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):1-5. PubMed ID: 26804357
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?
    Griffiths UK; Legood R; Pitt C
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):29-41. PubMed ID: 26775571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis.
    Dávalos ME; French MT; Burdick AE; Simmons SC
    Telemed J E Health; 2009 Dec; 15(10):933-48. PubMed ID: 19954346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economic guidelines--similarities, differences and some implications.
    Hjelmgren J; Berggren F; Andersson F
    Value Health; 2001; 4(3):225-50. PubMed ID: 11705185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The principles of cost-effectiveness analysis and their application.
    Zierler BK; Gray DT
    J Vasc Surg; 2003 Jan; 37(1):226-34. PubMed ID: 12514610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improving the transparency and credibility of cost-effectiveness analysis of healthcare interventions].
    Catalá-López F; Ridao M
    Rev Esp Salud Publica; 2016 Mar; 90():E1. PubMed ID: 27063024
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of cost-benefit and cost-effectiveness analyses of clinical pharmacy services.
    MacKeigan LD; Bootman JL
    J Pharm Mark Manage; 1988; 2(3):63-84. PubMed ID: 10312728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the costs and benefits of reducing hospital infection.
    Drummond MF; Davies LM
    J Hosp Infect; 1991 Jun; 18 Suppl A():85-93. PubMed ID: 1679832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.